• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别前驱帕金森病:帕金森病的运动前期障碍。

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

机构信息

Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada.

出版信息

Mov Disord. 2012 Apr 15;27(5):617-26. doi: 10.1002/mds.24996.

DOI:10.1002/mds.24996
PMID:22508280
Abstract

Increasing recognition that Parkinson's disease (PD) may start outside of the substantia nigra has led to a rapidly expanding effort to define prodromal stages of PD, before motor signs permit classical diagnosis. Many of these efforts center around the identification of clinical non-motor symptoms and signs of disease. There is now direct evidence that olfaction, rapid eye movement (REM) sleep behavior disorder (RBD), constipation, and depression can be present in prodromal PD. In addition, there is suggestive evidence that visual changes, other autonomic symptoms, and subtle cognitive changes may also be present at prodromal stages. A critical issue in utility of these prodromal markers will be assessment of sensitivity, specificity, and positive and negative predictive values. Although these have yet to be fully defined, olfactory deficits, some visual changes, and autonomic symptoms occur in the majority of PD patients at diagnosis, suggesting good potential sensitivity. However, with the exception of RBD and perhaps some specific autonomic measures, specificity, and positive predictive value of these markers may be insufficient to be used alone as identifiers of prodromal disease. The evidence for the utility of olfaction, RBD, autonomic markers, visual changes, mood disorders, and cognitive loss as markers of prodromal PD and the potential sensitivity and specificity of these markers are summarized.

摘要

越来越多的人认识到帕金森病(PD)可能始于黑质之外,这导致了人们迅速努力定义 PD 的前驱阶段,即在运动迹象允许进行经典诊断之前。这些努力中的许多都集中在识别临床非运动症状和疾病迹象上。现在有直接证据表明,嗅觉、快速眼动(REM)睡眠行为障碍(RBD)、便秘和抑郁可能存在于前驱期 PD 中。此外,有提示性证据表明,视觉变化、其他自主症状和细微的认知变化也可能存在于前驱阶段。这些前驱性标志物的实用性的一个关键问题将是评估其敏感性、特异性以及阳性和阴性预测值。尽管这些尚未得到充分定义,但嗅觉缺陷、一些视觉变化和自主症状在大多数 PD 患者的诊断中都存在,这表明其具有很好的潜在敏感性。然而,除了 RBD 之外,也许还有一些特定的自主测量指标,这些标志物的特异性和阳性预测值可能不足以单独作为前驱疾病的标识。本文总结了嗅觉、RBD、自主标志物、视觉变化、情绪障碍和认知丧失作为前驱 PD 标志物的效用证据,以及这些标志物的潜在敏感性和特异性。

相似文献

1
Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.识别前驱帕金森病:帕金森病的运动前期障碍。
Mov Disord. 2012 Apr 15;27(5):617-26. doi: 10.1002/mds.24996.
2
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.帕金森病如何开始?特发性 REM 睡眠行为障碍的前驱期帕金森病运动变化。
Brain. 2012 Jun;135(Pt 6):1860-70. doi: 10.1093/brain/aws093. Epub 2012 May 4.
3
[Does early detection of non-motor symptoms facilitate early treatment of Parkinson's disease?].[非运动症状的早期检测是否有助于帕金森病的早期治疗?]
Brain Nerve. 2012 Apr;64(4):453-61.
4
When does Parkinson's disease begin? From prodromal disease to motor signs.帕金森病何时开始?从前驱期疾病到运动症状。
Rev Neurol (Paris). 2012 Nov;168(11):809-14. doi: 10.1016/j.neurol.2012.07.004. Epub 2012 Sep 13.
5
Predicting Parkinson's disease - why, when, and how?预测帕金森病:为何、何时以及如何?
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S105-9. doi: 10.1016/S1353-8020(09)70793-X.
6
Screening for prodromal Parkinson's disease in the general community: a sleep-based approach.普通社区中帕金森病前驱期的筛查:一种基于睡眠的方法。
Sleep Med. 2016 May;21:101-5. doi: 10.1016/j.sleep.2015.12.016. Epub 2016 Mar 10.
7
Non-motor extranigral signs and symptoms in Parkinson's disease.帕金森病的非运动性外显体征和症状。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S6-12. doi: 10.1016/S1353-8020(09)70770-9.
8
[Non-motor symptoms in premotor phase of Parkinson disease].[帕金森病运动前期的非运动症状]
Rinsho Shinkeigaku. 2013;53(11):974-6. doi: 10.5692/clinicalneurol.53.974.
9
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.特发性快速眼动睡眠行为障碍中帕金森病的潜在早期标志物。
Neurology. 2006 Mar 28;66(6):845-51. doi: 10.1212/01.wnl.0000203648.80727.5b.
10
Biomarkers for the early detection of Parkinson's and Alzheimer's disease.用于帕金森病和阿尔茨海默病早期检测的生物标志物。
Neurodegener Dis. 2008;5(3-4):133-6. doi: 10.1159/000113682. Epub 2008 Mar 6.

引用本文的文献

1
Brain structural MRI marker for predicting conversion to Parkinson's disease in individuals with prodromal symptoms.用于预测前驱症状个体向帕金森病转化的脑结构磁共振成像标志物。
Front Aging Neurosci. 2025 Jul 16;17:1579326. doi: 10.3389/fnagi.2025.1579326. eCollection 2025.
2
Parkinson Disease Signaling Pathways, Molecular Mechanisms, and Potential Therapeutic Strategies: A Comprehensive Review.帕金森病信号通路、分子机制及潜在治疗策略:综述
Int J Mol Sci. 2025 Jul 3;26(13):6416. doi: 10.3390/ijms26136416.
3
Cortical macro- and microstructural changes in isolated rapid eye movement sleep behavior disorder.
孤立性快速眼动睡眠行为障碍中的皮质宏观和微观结构变化。
NPJ Parkinsons Dis. 2025 Jul 3;11(1):199. doi: 10.1038/s41531-025-01058-0.
4
Unsupervised subtyping of motor dysfunction of Parkinson's disease and its structural brain imaging correlates.帕金森病运动功能障碍的无监督亚型分类及其脑结构成像相关性。
Neuroimage Rep. 2025 Mar 1;5(1):100246. doi: 10.1016/j.ynirp.2025.100246. eCollection 2025 Mar.
5
Imaging advances to detect non-motor prodromal markers of Parkinson's disease and explore therapeutic translation opportunities.成像技术的进展用于检测帕金森病的非运动前驱标志物并探索治疗转化机会。
NPJ Parkinsons Dis. 2025 Jun 18;11(1):174. doi: 10.1038/s41531-025-01004-0.
6
Force control deficits in rapid eye movement behavior disorder and Parkinson's disease.快速眼动睡眠行为障碍和帕金森病中的力量控制缺陷。
Clin Neurophysiol. 2025 May 25;176:2110763. doi: 10.1016/j.clinph.2025.2110763.
7
Gut neuropeptide involvement in Parkinson's disease.肠道神经肽与帕金森病的关系。
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G716-G733. doi: 10.1152/ajpgi.00383.2024. Epub 2025 Apr 25.
8
Early detection of Parkinson's disease through multiplex blood and urine biomarkers prior to clinical diagnosis.在临床诊断之前,通过多种血液和尿液生物标志物早期检测帕金森病。
NPJ Parkinsons Dis. 2025 Feb 25;11(1):35. doi: 10.1038/s41531-025-00888-2.
9
Compensatory synaptotagmin-11 expression conceals parkinson's disease-like phenotypes in parkin knockout mice.代偿性突触结合蛋白-11表达掩盖了帕金蛋白基因敲除小鼠的帕金森病样表型。
Cell Commun Signal. 2025 Feb 3;23(1):61. doi: 10.1186/s12964-025-02037-x.
10
Prodromal Parkinson's disease and subsequent risk of Parkinson's disease and mortality.帕金森病前驱期及帕金森病后续发病风险和死亡率
NPJ Parkinsons Dis. 2025 Jan 9;11(1):14. doi: 10.1038/s41531-024-00863-3.